Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-009769

Chief Technical Officer gave up 6,507 shares (to pay taxes)

  • Chief Technical Officer acquired 16,968 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shulman Joseph Chief Technical Officer 2026-02-01 Option exercise +16,968 25,477 D
Shulman Joseph Chief Technical Officer 2026-02-01 Shares withheld for taxes −6,507 $108.99 $709,198 18,970 D
Derivatives
Shulman Joseph Chief Technical Officer 2026-02-01 Option exercise · Restricted Stock Units −2,656 0 D
Shulman Joseph Chief Technical Officer 2026-02-01 Option exercise · Restricted Stock Units −3,937 3,937 D
Shulman Joseph Chief Technical Officer 2026-02-01 Option exercise · Restricted Stock Units −4,125 8,250 D
Shulman Joseph Chief Technical Officer 2026-02-01 Option exercise · Restricted Stock Units −6,250 18,750 D
Loading xslF345X05/tm264963-7_4seq1.xml…